Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
1. At a Glance
- Central Sector Scheme of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, providing quality generic medicines at 50–80% lower MRP than branded equivalents through Jan Aushadhi Kendras (JAKs) [S1][S2].
- Implementing agency: Pharmaceuticals & Medical Devices Bureau of India (PMBI) — earlier called Bureau of Pharma PSUs of India (BPPI) [S3][S4].
- Flagship of India's push to cut out-of-pocket health expenditure (~70% of household health spend is on medicines); relevant for GS-II (health, governance) and GS-III (pharma sector) [S1].
2. Why in the News
- Janaushadhi Saptah 2026 (1–7 March 2026) and the 8th Janaushadhi Diwas on 7 March 2026 — nationwide health camps and outreach [S1][S2].
- PIB Backgrounder (7 Mar 2026) reaffirming the target of 25,000 Kendras by March 2027, with 18,000+ JAKs already operational [S1].
- Crossing of 100 crore Suvidha sanitary pads sold by 31 January 2026 [S3].
3. Background & Evolution
- Launched in 2008 as "Jan Aushadhi Campaign" by Department of Pharmaceuticals; re-launched and rebranded as PMBJP in November 2015 with expanded scope [S1].
- Implementing body BPPI established in December 2008 under DoP; later renamed PMBI [S3][S4].
- 2019: launched Jan Aushadhi Suvidha Oxo-biodegradable Sanitary Napkin at ₹1/pad and Jan Aushadhi Sugam mobile app [S3].
- Nov 2023: PM inaugurated the 10,000th Kendra at AIIMS Deoghar (Jharkhand) and announced expansion to 25,000 Kendras [S5].
- FY 2023-24: crossed ₹1,000 crore in annual sales [S6].
4. Core Static Facts
- Parent Ministry: Ministry of Chemicals & Fertilizers → Department of Pharmaceuticals [S1].
- Implementing Agency: PMBI (Pharmaceuticals & Medical Devices Bureau of India) — a society under DoP [S3].
- Scheme type: Central Sector Scheme (100% Union-funded) [S1].
- Product basket: 1,965 medicines + 293 surgical/consumable items across all major therapeutic groups (anti-infectives, anti-diabetics, cardiovascular, anti-cancer, GI) [S3].
- Current network: 18,646 JAKs (as of 28 Feb 2026) [S2]; target 25,000 by March 2027 [S1][S2].
- Footfall: ~10–12 lakh visitors per day [S2].
- Cumulative sales: ~₹7,700 crore MRP value by June 2025; estimated citizen savings ~₹38,000 crore vs branded equivalents [S2].
- Incentive to Kendra owners: up to ₹5 lakh general; special incentive up to ₹2 lakh for Women, SC/ST, Divyangjan, ex-servicemen, and Kendras in aspirational districts / NE / Himalayan / island regions [S1].
- Quality: medicines procured from WHO-GMP certified suppliers; tested at NABL-accredited labs [S1].
- Flagship products: Suvidha sanitary napkin at ₹1/pad (>100 crore pads sold by Jan 2026) [S1][S3].
- Digital interface: Jan Aushadhi Sugam app (launched 2019) — locate Kendras, check medicine price & stock [S3].
5. Multi-Dimensional Analysis
Economic / Health-financing - Cuts out-of-pocket expenditure (OOPE) — a key NHP-2017 goal of reducing OOPE to 25% of total health spend [S1]. - ~₹38,000 crore in cumulative consumer savings estimated by mid-2025 [S2].
Social / Equity - Franchisee model democratises pharma retail; reserved incentive of ₹2 lakh for women, SC/ST, Divyangjan and veterans promotes inclusive entrepreneurship [S1]. - ₹1 Suvidha napkin advances menstrual hygiene for low-income women; addresses period-poverty [S1][S3]. - Rural penetration through franchisee model addresses medicine deserts in remote areas [S1][S2].
Administrative / Governance - PMBI centrally procures and supplies via regional warehouses (e.g., Chennai, Gurugram, Guwahati, Surat) reducing logistics gaps [S4]. - Online application portal janaushadhi.gov.in for transparent allotment of Kendras [S2].
Scientific / Quality Assurance - All drugs WHO-GMP compliant; batch-wise testing at NABL labs — counters the prejudice that "generics = inferior" [S1].
Ethical - Aligns with Article 47 (DPSP) — State's duty to raise nutrition and public health; advances SDG-3 (Good Health) and SDG-3.8 (UHC, access to affordable essential medicines) [S1].
6. Recent Developments (last 12-18 months)
- 7 Mar 2026: PIB Backgrounder reiterating 25,000-Kendra target by March 2027 [S1].
- 1–7 Mar 2026: Janaushadhi Saptah 2026 with health camps across states incl. Assam, Andhra Pradesh [S2][S7].
- 31 Jan 2026: cumulative Suvidha napkin sales cross 100 crore units [S3].
- June 2025: cumulative sales ~₹7,700 crore (MRP); savings to citizens ~₹38,000 crore [S2].
- FY 2023-24: ₹1,000 crore annual sales target achieved [S6].
- Nov 2023: 10,000th Kendra at AIIMS Deoghar; expansion roadmap to 25,000 announced by PM [S5].
7. Prelims Hooks
- PMBJP launched in 2008; re-launched in November 2015 [S1].
- Implementing agency: PMBI (formerly BPPI, est. December 2008) [S3][S4].
- Parent ministry: Ministry of Chemicals & Fertilizers — Department of Pharmaceuticals (NOT Ministry of Health) [S1].
- Generic medicines priced 50–80% below branded MRP [S1][S2].
- Product basket: 1,965 medicines + 293 surgical items [S3].
- Suvidha sanitary napkin introduced in 2019, priced at ₹1/pad, oxo-biodegradable [S3].
- Jan Aushadhi Sugam app launched in 2019 [S3].
- 18,000+ JAKs operational; target 25,000 by March 2027 [S1][S2].
- Janaushadhi Diwas observed on 7 March annually (8th edition in 2026) [S1].
- 10,000th Kendra inaugurated by PM at AIIMS Deoghar (Jharkhand) in Nov 2023 [S5].
- Special incentive of ₹2 lakh for Women, SC/ST, Divyangjan, ex-servicemen [S1].
- Medicines sourced from WHO-GMP certified manufacturers; tested at NABL labs [S1].
- Cumulative savings estimated at ~₹38,000 crore to citizens (by June 2025) [S2].
8. Mains Relevance
- GS-II: Issues relating to development & management of Social Sector — Health; Welfare schemes for vulnerable sections.
- GS-III: Indian economy — issues of pharmaceutical sector, indigenous manufacturing, MSMEs.
- Question stems: 1. "Generic medicines alone cannot reduce out-of-pocket health expenditure unless prescription practices change." Critically examine in the context of PMBJP. (GS-II) 2. Evaluate PMBJP as an instrument of inclusive entrepreneurship and last-mile health access, citing its incentive structure and Suvidha sub-scheme. (GS-II) 3. Discuss the role of PMBI and the franchisee model in operationalising the National Health Policy 2017 goal of universal access to essential medicines. (GS-II)
9. Related Topics to Study Next
- National Health Policy 2017 — sets OOPE-reduction target PMBJP serves.
- Ayushman Bharat (PM-JAY & HWCs) — complementary affordable-care pillar.
- DPCO 2013 & NPPA — price-control regime for essential medicines.
- National List of Essential Medicines (NLEM 2022) — overlap with Jan Aushadhi basket.
- Production Linked Incentive (PLI) for Pharma & Bulk Drugs — supply-side complement.
- Pradhan Mantri Bhartiya Janaushadhi Kendra (PMBJK) franchisee guidelines — operational layer.
- SDG-3 (UHC) and Article 47 DPSP — normative anchor.
- Suvidha napkin & Menstrual Hygiene Scheme (MoHFW) — gender-health convergence.
10. Common Errors / Trap Areas
- Wrong ministry: PMBJP is under DoP / Min. of Chemicals & Fertilizers, NOT Ministry of Health & Family Welfare [S1].
- BPPI vs PMBI: agency was renamed — current name is PMBI [S3].
- Launch year confusion: scheme originated in 2008; re-launched/rebranded as PMBJP in 2015 — both dates examinable [S1].
- Suvidha napkin price: ₹1 per pad (often misquoted as ₹2.50, the original 2018 price) [S1][S3].
- Janaushadhi Diwas date: 7 March (not 1 March or 8 March) [S1].
- PMBJP supplies generic medicines, not "free" medicines — they are sold, only cheaper.
11. Sources
- [S1] PIB Backgrounder — PMBJP: Advancing Affordable and Equitable Healthcare (7 Mar 2026) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2236292 — (tier: 1)
- [S2] Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) — Press Note — https://www.pib.gov.in/PressNoteDetails.aspx?NoteId=157711&ModuleId=3®=5&lang=16 — (tier: 1)
- [S3] PMBJP, BPPI & stakeholders — essential medicines at affordable prices — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1718623 — (tier: 1)
- [S4] Inauguration of Regional Warehouse of PMBJP at Chennai — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1583499 — (tier: 1)
- [S5] PM inaugurates 10,000th Jan Aushadhi Kendra at AIIMS Deoghar — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1981190 — (tier: 1)
- [S6] PMBJP achieves ₹1000 Cr sales target in FY 2023-24 — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1988675 — (tier: 1)
- [S7] Janaushadhi Saptah 2026 kicks off with Health Camps — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2234273 — (tier: 1)